OQROGet OQRO Pro
Insider trade

Adaptive Biotechnologies (ADPT)CEO sold ~$253K

Chad M Robins, CEO at Adaptive Biotechnologies, sold ~$253K of Adaptive Biotechnologies shares.

~$253K
Approx. value · 36K sh @ $6.99
2.81M
Holds after · shares reported
Traded
Mar 5, 2025
Filed
Mar 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 13, 2025InsiderCEO sold ~$846K of ADPT shares in the open market
  2. Feb 14, 2025InsiderCEO sold ~$1.34M of ADPT shares in the open market
  3. Feb 18, 2025InsiderCEO sold ~$1.79M of ADPT shares in the open market
  4. Feb 19, 2025InsiderCEO sold ~$1.57M of ADPT shares in the open market
  5. Feb 20, 2025InsiderCEO sold ~$836K of ADPT shares in the open market
  6. Mar 5, 2025 · this disclosureInsiderCEO sold ~$253K of ADPT shares in the open market

What came next

  1. Mar 5, 2025Insider · 7 peopleInsiders: 13 sales (~$2.4M)
  2. Mar 6, 2025Insider · 2 peopleInsiders: 2 sales (~$905K)
  3. Mar 10, 2025InsiderDirector sold ~$71K of ADPT shares in the open market
  4. Mar 12, 2025InsiderDirector sold ~$402K of ADPT shares in the open market
  5. Mar 13, 2025InsiderDirector sold ~$261K of ADPT shares in the open market
  6. Mar 24, 2025InsiderOfficer sold ~$15K of ADPT shares in the open market
  7. May 1, 2025InsiderOfficer sold ~$503K of ADPT shares in the open market
  8. May 16, 2025InsiderCFO sold ~$17K of ADPT shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Adaptive Biotechnologies

For Adaptive Biotechnologies, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 9 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADPT page.

Other recent filings by Chad M Robins, CEO and Chairman

The full history of Chad M Robins, CEO and Chairman is on the profile page.

How this filing works

Other disclosures at Adaptive Biotechnologies

Everything OQRO holds on this company is on its ADPT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data